Corcept Therapeutics (CORT) Tops Q3 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St set for higher open as investors weigh Mideast negotiations
- Oil falls after US-Iran talks signal easing supply risks
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Corcept Therapeutics Announces Third Quarter 2015 Results and Provides Corporate Update
November 5, 2015 4:06 PM ESTMENLO PARK, CA -- (Marketwired) -- 11/05/15 -- Corcept Therapeutics Incorporated (NASDAQ: CORT)
GAAP net loss in the third quarter narrows to $0.6 million, from $6.0 million in the third quarter of 2014 Non-GAAP net income in the third quarter increases to $1.6 million, compared to a non-GAAP net loss of $3.9 million in the third quarter of 2014 Third quarter revenue grows to $13.3 million, compared to $7.3 million in the third quarter of 2014, an 82 percent increase; the company reiterates its 2015 revenue guidance of $49 - $53 million... More